Check out our most popular compounded medications! Get Started
Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) is a semisolid formulation, dispensed through a pump for easy and precise application. This compounded medication is used for targeted treatment of conditions such as arthritis, dermatitis, wounds, pain, and inflammation in animals, delivering the active ingredients directly through the skin.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) is a specially compounded medication designed for veterinary use. It is primarily used to alleviate pain, arthritis, osteoarthritis, inflammation, and dyspnea in animals. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredient, Buprenorphine, is absorbed through the skin, targeting the affected area directly.
Buprenorphine is an opioid agonist that works by binding to opioid receptors in the body. This action provides analgesic and anti-inflammatory effects, offering relief from pain and inflammation. Additionally, Buprenorphine is known to reduce dyspnea, or shortness of breath, by relaxing the airways and reducing inflammation.
The gel-like consistency of this formulation ensures it adheres well to the skin, allowing for optimal absorption of the active ingredient.
It is crucial to understand that this formulation should only be used under the supervision of a veterinarian. It is not intended for human use. Misuse can lead to serious health consequences. Always consult with a veterinarian before starting any new medication regimen for your pet.
If you have any questions about Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) or how it can be used to treat various conditions in animals, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is well-equipped to provide the information and guidance you need.
Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) is a specialized compounded formulation designed to provide targeted relief for a variety of conditions in animals. This includes pain, arthritis, osteoarthritis, inflammation, and dyspnea. The active ingredient, buprenorphine, works by blocking the pain signals sent to the brain, thereby reducing inflammation and providing relief from dyspnea.
Research has demonstrated the effectiveness of buprenorphine in reducing pain and inflammation associated with arthritis and osteoarthritis. It has also been shown to provide relief from dyspnea, a condition characterized by difficult or labored breathing. However, it is crucial to note that buprenorphine should not be used in patients with a history of opioid abuse or addiction. It should also be avoided in patients with a history of hypersensitivity to buprenorphine or any of its components.
Patients should be closely monitored for signs of opioid overdose, which can include symptoms such as respiratory depression, sedation, and coma. If any of these signs are present, the patient should be immediately evaluated and treated. Furthermore, buprenorphine should not be used in combination with other opioid medications, as this may increase the risk of overdose.
It is always recommended to consult with a veterinary professional before starting any new medication regimen. If you have any questions about the use of Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) for the treatment of pain, arthritis, osteoarthritis, inflammation, and dyspnea, please consult with a veterinary professional.
Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet) is a semisolid formulation designed for easy and precise application on the skin. This veterinary medication is primarily used for the management of pain, arthritis, osteoarthritis, inflammation, and dyspnea in animals. The gel is dispensed through a pump mechanism, allowing for targeted treatment of the affected area. Once applied, the active ingredient, Buprenorphine, is absorbed through the skin, working to block pain signals sent to the brain and reduce inflammation, thereby providing relief from pain and discomfort.
Buprenorphine is a potent opioid analgesic and should be used with caution. It is crucial to use this medication strictly as directed by a veterinary healthcare professional. The instructions provided by your vet should be followed meticulously to ensure the safety and effectiveness of the treatment. The gel should not be applied to broken or irritated skin, and its use should not exceed a two-week period without consulting a healthcare provider.
When applying the gel, care should be taken to avoid contact with the eyes, nose, and mouth. If you have any questions or concerns about the use of Buprenorphine 0.3 mg/0.1 ml Topical Gel (Vet), it is recommended to consult with your veterinary healthcare provider for further guidance and information.
This is a semisolid formulation of Buprenorphine, an opioid medication, designed for topical application on the skin of animals. It is dispensed through a pump mechanism for easy and precise application.
The pump mechanism allows for easy and precise application of the gel on the skin. It dispenses a controlled amount of the medication, ensuring the correct dosage is applied each time.
The gel has a semisolid, gel-like consistency that allows it to be easily spread on the skin for targeted treatment.
The purpose of this topical gel is to deliver the active ingredient, Buprenorphine, directly to the targeted area on the skin for absorption. This provides localized treatment and can help manage pain in animals.
This gel is applied directly to the skin of the animal in the area that requires treatment. The pump mechanism allows for easy and precise application.
It's important to consult with a veterinarian before using this medication on any animal. The vet will determine if this is the appropriate treatment based on the animal's condition and overall health.
As with any medication, there can be potential side effects. These can include skin irritation at the application site, changes in behavior, or other adverse reactions. If any unusual symptoms are observed, contact a veterinarian immediately.
This gel should be stored in a cool, dry place, away from direct sunlight. Always keep it out of reach of children and pets.
If a dose is missed, apply the gel as soon as possible. However, if it's close to the time for the next dose, skip the missed dose and continue with the regular dosing schedule. Never apply a double dose to make up for a missed one.
Before using this gel in conjunction with other medications, it's important to consult with a veterinarian. They will be able to advise on potential interactions and whether it's safe to use together.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
